+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Urinary Incontinence Drug"

Urinary Incontinence - Pipeline Insight, 2024 - Product Thumbnail Image

Urinary Incontinence - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Stress Urinary Incontinence - Pipeline Insight, 2024 - Product Thumbnail Image

Stress Urinary Incontinence - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
Urinary Incontinence Global Market Report 2024 - Product Thumbnail Image

Urinary Incontinence Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
Stress Urinary incontinence - Epidemiology Forecast - 2032 - Product Thumbnail Image

Stress Urinary incontinence - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Urinary Incontinence - Epidemiology Forecast to 2032 - Product Thumbnail Image

Urinary Incontinence - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
From
Urinary Incontinence Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Urinary Incontinence Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • January 2020
  • 318 Pages
  • Global
From
Loading Indicator

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers. Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more